A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group
about
Endotoxemia in critically ill patients: why a reliable test could be beneficial.alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in miceProtection against lipopolysaccharide-induced death by fluoroquinolones.Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4Nitric oxide and septic shock. From bench to bedsideBaicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis.Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies.The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndromeClinical and Autopsy Diagnoses of Visceral Affections of Patients Who Died Because of Complicated Burns with Multi-organ Failure.Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsisLack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.Immunoparalysis and adverse outcomes from critical illness.Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.The immune response: targets for the treatment of severe sepsis.Cytokines in the systemic inflammatory response syndrome: a reviewMicrobial recognition and danger signals in sepsis and trauma.Alteco endotoxin hemoadsorption in Gram-negative septic shock patientsAntimicrobial peptides for gram-negative sepsis: a case for the polymyxins.Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in micePneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters.Biomechanical aspects of the auto-digestion theory.Relationship between endotoxin core, staphylococcal and varicella antibody levels and outcome following aortic valve replacement surgery: a prospective observational study
P2860
Q24796837-1CEDA48F-4E66-404A-9803-7EA4922AA178Q28368431-A989DFB4-A926-4DC0-9A26-503207E59F15Q28379429-5FAA9659-D69F-4826-8036-9AF5C5582094Q33594884-6EF3B969-FF14-4F8C-9DBE-1D13ADE2D118Q33631108-5839CBD3-CE89-4266-BC29-92BBCD69F46EQ34187914-08FD011A-94CA-440E-9035-1747514FEFD1Q34270607-73F7330C-D8BD-4270-9FB7-2DB8CB64E14FQ34726541-1D276630-AD6D-446B-8CD9-C8B8AC180402Q35052920-71AC3A96-56E4-4DDD-9625-BAAA0CF94C33Q35228954-80CA0F62-65D0-4B85-9D4E-9311B3964FF8Q35279262-7495FEF5-91AC-405E-A8AA-9657F921B157Q35586916-6499C5B7-876C-4000-8B9A-AEA47C07E704Q35690018-D44D7DC4-C10C-4528-9795-14CC09FF842FQ36310139-6F032BAB-7F1D-41B8-BF48-99EEF128D1B0Q36775843-53FBD8C3-C844-4A61-84AE-0AD6CD27BB91Q36838630-D84EEAAF-AB0D-46FD-93A4-E787ED7C0EBFQ37367885-B4438C8B-C993-4F69-955B-735BA457A16BQ38068423-5057A483-9B03-4928-8488-5E31736F0D31Q38084633-F804DE60-07D3-4FE9-9B85-FC6699844410Q39099480-80072557-44D2-4123-B858-3C7DC70CE4B5Q41946739-49E21D7F-FDDD-4BD1-892B-2833B9050AD1Q42276631-D8B7A593-9329-45AB-AB9C-C43DBA61E0EAQ42586828-D3B59E02-3674-4056-9CE9-476986421032Q44481437-5F59924D-34FF-4597-9FFC-210C4BB58D8AQ55070889-67202476-9E10-4E9F-8FF2-54A1F70D39BFQ58714088-45806E1B-5415-4C5C-8B8F-C4F2EA9E1FBA
P2860
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@ast
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@en
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@nl
type
label
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@ast
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@en
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@nl
prefLabel
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@ast
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@en
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@nl
P2093
P921
P1476
A second large controlled clin ...... ial. The E5 Sepsis Study Group
@en
P2093
H D Reines
N Macintyre
R M Schein
R P Wenzel
R W Quenzer
T J Iberti
P304
P407
P577
1995-06-01T00:00:00Z